MFDS
- Marketing authorisation holder: INCYTE CORP
- Status: likely_approved
🇰🇷 Niktimvo in South Korea
Niktimvo (AXATILIMAB) regulatory status in South Korea.
Marketing authorisation
Niktimvo in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in South Korea
Frequently asked questions
Is Niktimvo approved in South Korea?
Yes. MFDS has authorised it.
Who is the marketing authorisation holder for Niktimvo in South Korea?
INCYTE CORP holds the South Korean marketing authorisation.